The debut of the ICD-10 diagnostic codes topped the list, followed by California’s approval of physician-assisted suicide. The end of the 10-year MOC exam ranked as the most exciting piece of news. Medscape Medical News
rhNGF, la molecola biotecnologica Dompé per la cura della cheratite neurotrofica, designato farmaco orfano dalla European Medicines Agency
MILANO–(BUSINESS WIRE)–L’azienda biofarmaceutica Dompé annuncia che il Comitato per i Farmaci Orfani dell’EMA (European Medicines Agency) ha ufficialmente designato rhNGF, la molecola biotecnologica sperimentale messa a punto dalla ricerca Dompé sulla scorta degli studi del Premio Nobel per la Medicina Rita Levi Montalcini, come farmaco orfano per il trattamento della cheratite neurotrofica. NGF (Nerve Growth Factor) è il primo fattore neurotrofico a essere identificato e purificato e, oggi,
rhNGF, the Dompé Biotech Molecule for the Treatment of Neurotrophic Keratitis, Receives Orphan Drug Designation from the European Medicines Agency
MILAN–(BUSINESS WIRE)–The Dompé biopharmaceutical company announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has officially designated recombinant human Nerve Growth Factor (rhNGF) – the investigational biotech molecule developed by Dompé based on research by Nobel Laureate Rita Levi Montalcini – as an orphan drug for the treatment of neurotrophic keratitis. NGF is the first neurotrophic factor to be identified and purified, and represents
Uncategorized
Trabeculectomy has little impact on IOL power calculations
Trabeculectomy had a minimal effect on IOL power calculation despite significant changes in axial length and corneal power, according to a study.The prospective study included 34 eyes of 31 patients with a mean age of 53.35 years who were scheduled to …
Doc Groups Urge Congress to Drop Gun Research Ban
(MedPage Today) — Let the CDC do research on firearm violence, they say
Ptosis and Diplopia in a 74-Year-Old With History of Stroke
Five years after her initial hospitalization, a patient returns with ptosis and diplopia. Are these a sign that another stroke has occurred, or is a different diagnosis called for? Medscape Ophthalmology